EV/EBITDA Multiple: Radius Health (RDUS)

Corporate company logo of radiuspharm.com (RDUS)

Radius Recycling, Inc. (RDUS) is a biopharmaceutical player whose model is based on patent monetization following high R&D expenditures, which creates powerful operating leverage. This chart illustrating the price evolution of the quotes on GURU.Markets shows an EV/EBITDA of , while component supplies for tests are guaranteed by long-term contracts and flexible logistics. However, the business remains susceptible to electricity costs, environmental requirements, and automotive industry cycles.

RDUS (Radius Recycling Inc.) Enterprise Value to Operating Income Before Depreciation Ratio history from 07/04/2022 to 11/12/2026

radiuspharm.com (RDUS) - metric breakdowns and financial figures

- market price and analyst price targets:
Price Chart Radius Health|RDUS - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization Radius Pharmaceuticals|RDUS - Total Enterprise Value
- issuer book value statistics:
Accounting Value per Share Radius Recycling|RDUS - Total Net Assets|Market Capitalization to Book Value Ratio radiuspharm.com|RDUS - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Radius Recycling, Inc.|RDUS - Long-Term Debt to Equity|Short-Term Debt to Equity Radius Recycling|RDUS - Company Cumulative Debt|Debt to Book Capitalization Ratio Radius Pharmaceuticals|RDUS - Company Long-Term Debt|Company Short-Term Debts Radius Recycling|Quick Liquidity radiuspharm.com
- net income and valuation multiples indicators:
RDUS - Net Financial Result|Expected Profit Radius Recycling, Inc.|RDUS - Price to Earnings Ratio|Future Price to Earnings Radius Recycling, Inc.|RDUS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Radius Pharmaceuticals|RDUS - Operating profit EBITDA|Net earnings per share (EPS TTM) Radius Recycling|RDUS - Earnings per share for the last 12 months|Quarterly EPS earnings growth radiuspharm.com|RDUS - Expected net earnings per share growth this year|Expected earnings per share growth for next year Radius Recycling, Inc.
Initial company analysis:RDUS (Radius Health)
Product sample of Radius Recycling

Radius Recycling, Inc. (RDUS) is transforming the scrap recycling model through energy-efficient shredding and logistical optimization amid a cyclical market. The EV/EBITDA multiple trend reflects the revaluation speed of this capital-intensive business, accounting for its debt load. The ratio of enterprise value to operating profit allows for the identification of asset overpayment and the determination of the actual risk premium.

Who Radius Recycling, Inc. competes with

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ascendis Pharma Inc. ASND|MDGL - Enterprise Value to EBITDA Ratio|Corcept Therapeutics - EV/EBITDA Multiple|Company Value to EBITDA rhythmtx.com|AKRO (Akero) - Enterprise Value to EBITDA Ratio|MTSR: Enterprise Value to Operating Income Before Depreciation Ratio|MLTX (MoonLake Pharma) - EV/EBITDA Multiple|EV/EBITDA Multiple Crinetics Corp|EV/EBITDA Multiple NAMS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SLNO (soleno.life)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Amicus Therapeutics, Inc. FOLD|89bio Inc (ETNB) - Company Value to EBITDA|AGIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GPCR: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDXG: EV/EBITDA Multiple|RZLT - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lexicon Pharmaceuticals, Inc.|MBX Biosciences, Inc. (MBX) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Altimmune Corp (ALT)|Enterprise Value to EBITDA Ratio Aardvark Pharma AARD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sagimet Biosciences SGMT|Business Value to Operating Income Before Depreciation BIOA|Biomea Fusion - EV/EBITDA Multiple|QNCX - EV/EBITDA Multiple|GUTS: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation VTVT|ATPC (Agape ATP Corp) - EV/EBITDA Multiple|Pluri Inc (PLUR) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio SYBX (Synlogic, Inc.)|EV/EBITDA Multiple Lipocine Inc (LPCN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Matinas BioPharma Holdings MTNB|Total Company Value to Operating Income Before Depreciation Ratio sprucebiosciences.com (SPRB)|GLTO: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation CTCX (carmellrx.com)|Lumos Pharma (LUMO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Organovo Holdings - Business Value to Operating Income Before Depreciation